CN1921858A - 哌啶基烷基氨基甲酸酯衍生物、其制备方法及其作为faah酶抑制剂的应用 - Google Patents

哌啶基烷基氨基甲酸酯衍生物、其制备方法及其作为faah酶抑制剂的应用 Download PDF

Info

Publication number: CN1921858A
Authority: CN; China
Prior art keywords: group; general formula; phenyl; groups; compound
Prior art date: 2004-02-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

CNA2005800058637A

Other languages

English (en)

Chinese (zh)

Inventor

A·阿布亚布德拉

A·阿尔马里奥加西亚

C·霍奈尔特

J·热纳斯

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanofi Aventis France

Original Assignee

Sanofi Aventis France

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-26

Filing date

2005-02-25

Publication date

2007-02-28

2005-02-25 Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France

2007-02-28 Publication of CN1921858A publication Critical patent/CN1921858A/zh

Status Pending legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Physical Education & Sports Medicine (AREA)
Virology (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Psychiatry (AREA)
Ophthalmology & Optometry (AREA)
Hospice & Palliative Care (AREA)
Molecular Biology (AREA)
Otolaryngology (AREA)
Tropical Medicine & Parasitology (AREA)
Hematology (AREA)
Psychology (AREA)
Nutrition Science (AREA)

CNA2005800058637A 2004-02-26 2005-02-25 哌啶基烷基氨基甲酸酯衍生物、其制备方法及其作为faah酶抑制剂的应用 Pending CN1921858A (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0401952		2004-02-06
FR0401952A FR2866885B1 (fr)	2004-02-26	2004-02-26	Derives de piperidinylalkylcarbamates, leur prepation et leur application en therapeutique

Publications (1)

Publication Number	Publication Date
CN1921858A true CN1921858A (zh)	2007-02-28

Family

ID=34834069

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CNA2005800058637A Pending CN1921858A (zh)	2004-02-26	2005-02-25	哌啶基烷基氨基甲酸酯衍生物、其制备方法及其作为faah酶抑制剂的应用

Country Status (26)

Country	Link
US (2)	US7781590B2 (pl)
EP (1)	EP1720550B1 (pl)
JP (1)	JP4796046B2 (pl)
KR (1)	KR20060134081A (pl)
CN (1)	CN1921858A (pl)
AR (1)	AR047818A1 (pl)
AT (1)	ATE428417T1 (pl)
AU (1)	AU2005224140B2 (pl)
BR (1)	BRPI0508072A (pl)
CA (1)	CA2554608A1 (pl)
CY (1)	CY1109231T1 (pl)
DE (1)	DE602005013923D1 (pl)
DK (1)	DK1720550T3 (pl)
ES (1)	ES2325376T3 (pl)
FR (1)	FR2866885B1 (pl)
HR (1)	HRP20090294T1 (pl)
IL (1)	IL177534A (pl)
MA (1)	MA28366A1 (pl)
NZ (1)	NZ550007A (pl)
PL (1)	PL1720550T3 (pl)
PT (1)	PT1720550E (pl)
RU (1)	RU2384569C2 (pl)
SI (1)	SI1720550T1 (pl)
TW (1)	TW200529816A (pl)
WO (1)	WO2005089759A1 (pl)
ZA (1)	ZA200606964B (pl)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102459232A (zh) *	2009-05-12	2012-05-16	赛诺菲	7-氮杂-螺[3.5]壬烷-7-甲酸酯衍生物、其制备及其治疗用途
CN102369200B (zh) *	2009-02-05	2015-05-20	赛诺菲	5元杂环化合物的氮杂螺烷基-烷基氨基甲酸酯衍生物、其制备方法和其治疗用途

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2866888B1 (fr) *	2004-02-26	2006-05-05	Sanofi Synthelabo	Derives de alkylpiperazine- et alkylhomopiperazine- carboxylates, leur preparation et leur application en therapeutique
FR2866886B1 (fr) *	2004-02-26	2007-08-31	Sanofi Synthelabo	Derives d'aryl-et d'heteroaryl-akylcarbamates, leur preparation et leur application en therapeutique
FR2866884B1 (fr) *	2004-02-26	2007-08-31	Sanofi Synthelabo	Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique
US7541359B2 (en)	2005-06-30	2009-06-02	Janssen Pharmaceutica N.V.	N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase
US20090111778A1 (en) *	2005-11-18	2009-04-30	Richard Apodaca	2-Keto-Oxazoles as Modulators of Fatty Acid Amide Hydrolase
CA2632030A1 (en)	2005-12-15	2007-06-21	Boehringer Ingelheim International Gmbh	Compounds which modulate the cb2 receptor
WO2008014199A2 (en)	2006-07-28	2008-01-31	Boehringer Ingelheim International Gmbh	Sulfonyl compounds which modulate the cb2 receptor
KR20090069318A (ko)	2006-09-25	2009-06-30	베링거 인겔하임 인터내셔날 게엠베하	Ｃｂ2 수용체를 조절하는 화합물
EP2217565B1 (en)	2007-11-07	2013-05-22	Boehringer Ingelheim International GmbH	Compounds which modulate the cb2 receptor
EP2326629B1 (en)	2008-07-10	2013-10-02	Boehringer Ingelheim International GmbH	Sulfone compounds which modulate the cb2 receptor
CA2737645A1 (en)	2008-09-25	2010-04-01	Boehringer Ingelheim International Gmbh	Compounds which selectively modulate the cb2 receptor
US8299103B2 (en)	2009-06-15	2012-10-30	Boehringer Ingelheim International Gmbh	Compounds which selectively modulate the CB2 receptor
WO2010147791A1 (en)	2009-06-16	2010-12-23	Boehringer Ingelheim International Gmbh	Azetidine 2 -carboxamide derivatives which modulate the cb2 receptor
EP2480544A1 (en)	2009-09-22	2012-08-01	Boehringer Ingelheim International GmbH	Compounds which selectively modulate the cb2 receptor
EP2523936A1 (en)	2010-01-15	2012-11-21	Boehringer Ingelheim International GmbH	Compounds which modulate the cb2 receptor
US8329735B2 (en)	2010-03-05	2012-12-11	Boehringer Ingelheim International Gmbh	Tetrazole compounds which selectively modulate the CB2 receptor
WO2012012307A1 (en)	2010-07-22	2012-01-26	Boehringer Ingelheim International Gmbh	Sulfonyl compounds which modulate the cb2 rece
EP2803668A1 (en)	2013-05-17	2014-11-19	Boehringer Ingelheim International Gmbh	Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3235565A1 (de) *	1982-09-25	1984-03-29	Boehringer Ingelheim KG, 6507 Ingelheim	Piperidinderivate, ihre herstellung und verwendung
RU2216540C2 (ru) *	1997-11-18	2003-11-20	Тейджин Лимитед	Производные циклических аминов, способ ингибирования
AU740588B2 (en) *	1997-11-24	2001-11-08	Scripps Research Institute, The	Inhibitors of gap junction communication
MXPA03009850A (es) *	2001-04-27	2004-02-12	Bristol Myers Squibb Co	Inhibidores de bisarilimidazolil de hidrolasa de amida del acido graso.
PL373970A1 (pl) *	2002-02-08	2005-09-19	Bristol-Myers Squibb Company	(Oksymo) karbamoilowe inhibitory hydrolazy amidówkwasów tłuszczowych
FR2843964B1 (fr) *	2002-08-29	2004-10-01	Sanofi Synthelabo	Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
FR2850377B1 (fr) *	2003-01-23	2009-02-20	Sanofi Synthelabo	Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
FR2854633B1 (fr) *	2003-05-07	2005-06-24	Sanofi Synthelabo	Derives de piperidinyl-et piperazinyl-alkylcarbamates, leur preparation et leur application en therapeutique
FR2860514A1 (fr) *	2003-10-03	2005-04-08	Sanofi Synthelabo	Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
FR2866886B1 (fr) *	2004-02-26	2007-08-31	Sanofi Synthelabo	Derives d'aryl-et d'heteroaryl-akylcarbamates, leur preparation et leur application en therapeutique

2004
- 2004-02-26 FR FR0401952A patent/FR2866885B1/fr not_active Expired - Fee Related
2005
- 2005-02-24 AR ARP050100668A patent/AR047818A1/es unknown
- 2005-02-25 WO PCT/FR2005/000452 patent/WO2005089759A1/fr not_active Ceased
- 2005-02-25 KR KR1020067017251A patent/KR20060134081A/ko not_active Abandoned
- 2005-02-25 JP JP2007500261A patent/JP4796046B2/ja not_active Expired - Fee Related
- 2005-02-25 PT PT05732905T patent/PT1720550E/pt unknown
- 2005-02-25 RU RU2006134025/04A patent/RU2384569C2/ru not_active IP Right Cessation
- 2005-02-25 ZA ZA200606964A patent/ZA200606964B/xx unknown
- 2005-02-25 HR HR20090294T patent/HRP20090294T1/xx unknown
- 2005-02-25 CN CNA2005800058637A patent/CN1921858A/zh active Pending
- 2005-02-25 BR BRPI0508072-0A patent/BRPI0508072A/pt not_active IP Right Cessation
- 2005-02-25 PL PL05732905T patent/PL1720550T3/pl unknown
- 2005-02-25 DE DE602005013923T patent/DE602005013923D1/de not_active Expired - Lifetime
- 2005-02-25 SI SI200530727T patent/SI1720550T1/sl unknown
- 2005-02-25 AT AT05732905T patent/ATE428417T1/de active
- 2005-02-25 EP EP05732905A patent/EP1720550B1/fr not_active Expired - Lifetime
- 2005-02-25 TW TW094105855A patent/TW200529816A/zh unknown
- 2005-02-25 ES ES05732905T patent/ES2325376T3/es not_active Expired - Lifetime
- 2005-02-25 NZ NZ550007A patent/NZ550007A/en unknown
- 2005-02-25 DK DK05732905T patent/DK1720550T3/da active
- 2005-02-25 CA CA002554608A patent/CA2554608A1/fr not_active Abandoned
- 2005-02-25 AU AU2005224140A patent/AU2005224140B2/en not_active Ceased
2006
- 2006-08-16 IL IL177534A patent/IL177534A/en not_active IP Right Cessation
- 2006-08-21 US US11/465,825 patent/US7781590B2/en not_active Expired - Fee Related
- 2006-08-22 MA MA29284A patent/MA28366A1/fr unknown
2009
- 2009-07-14 CY CY20091100744T patent/CY1109231T1/el unknown
2010
- 2010-07-12 US US12/834,267 patent/US20100279998A1/en not_active Abandoned

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102369200B (zh) *	2009-02-05	2015-05-20	赛诺菲	5元杂环化合物的氮杂螺烷基-烷基氨基甲酸酯衍生物、其制备方法和其治疗用途
CN102459232A (zh) *	2009-05-12	2012-05-16	赛诺菲	7-氮杂-螺[3.5]壬烷-7-甲酸酯衍生物、其制备及其治疗用途
CN102459232B (zh) *	2009-05-12	2014-05-07	赛诺菲	7-氮杂-螺[3.5]壬烷-7-甲酸酯衍生物、其制备及其治疗用途

Also Published As

Publication number	Publication date
TW200529816A (en)	2005-09-16
DK1720550T3 (da)	2009-08-10
MA28366A1 (fr)	2006-12-01
IL177534A0 (en)	2006-12-10
DE602005013923D1 (de)	2009-05-28
SI1720550T1 (sl)	2009-10-31
AU2005224140B2 (en)	2010-12-02
CA2554608A1 (fr)	2005-09-29
US20100279998A1 (en)	2010-11-04
AU2005224140A1 (en)	2005-09-29
ATE428417T1 (de)	2009-05-15
PT1720550E (pt)	2009-06-04
RU2006134025A (ru)	2008-04-10
WO2005089759A1 (fr)	2005-09-29
US7781590B2 (en)	2010-08-24
NZ550007A (en)	2010-06-25
JP4796046B2 (ja)	2011-10-19
KR20060134081A (ko)	2006-12-27
HRP20090294T1 (en)	2009-06-30
ZA200606964B (en)	2008-01-30
BRPI0508072A (pt)	2007-07-17
EP1720550A1 (fr)	2006-11-15
FR2866885A1 (fr)	2005-09-02
RU2384569C2 (ru)	2010-03-20
CY1109231T1 (el)	2014-07-02
FR2866885B1 (fr)	2007-08-31
ES2325376T3 (es)	2009-09-02
AR047818A1 (es)	2006-02-22
US20070021403A1 (en)	2007-01-25
IL177534A (en)	2011-01-31
JP2007524706A (ja)	2007-08-30
PL1720550T3 (pl)	2009-09-30
EP1720550B1 (fr)	2009-04-15

Legal Events

Date	Code	Title	Description
2007-02-28	C06	Publication
2007-02-28	PB01	Publication
2007-05-02	C10	Entry into substantive examination
2007-05-02	SE01	Entry into force of request for substantive examination
2008-01-04	REG	Reference to a national code	Ref country code: HK Ref legal event code: DE Ref document number: 1103970 Country of ref document: HK
2010-08-11	C12	Rejection of a patent application after its publication
2010-08-11	RJ01	Rejection of invention patent application after publication	Open date: 20070228
2013-09-19	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1103970 Country of ref document: HK

Publication	Publication Date	Title
CN1056605C (zh)	2000-09-20	作为人速激肽ⅲ受体的选择性拮抗剂的化合物及其用途
CN1089764C (zh)	2002-08-28	取代的杂环化合物,其制备方法和含有这些化合物的药物组合物
CN1304382C (zh)	2007-03-14	用于治疗炎性、免疫或心血管疾病的新的p2x7受体拮抗剂
CN1187326C (zh)	2005-02-02	新化合物
CN1257891C (zh)	2006-05-31	含氮五员环化合物
CN1230421C (zh)	2005-12-07	酰胺化合物及其药物用途
CN1812980A (zh)	2006-08-02	哌啶基－和哌嗪基－烷基氨基甲酸酯衍生物,其制备及治疗用途
CN1922161A (zh)	2007-02-28	1－哌嗪－和1－高哌嗪－羧酸酯衍生物、制备和其治疗用途
CN1922177A (zh)	2007-02-28	芳基－和杂芳基－哌啶甲酸衍生物，它们的制备方法与作为faah酶抑制剂的应用
HK1049118A1 (zh)	2003-05-02	金属蛋白酶抑制剂
CN1681801A (zh)	2005-10-12	喹啉基丙基哌啶衍生物以及其作为抗微生物剂的应用
CN1780621A (zh)	2006-05-31	作为γ分泌酶抑制剂的磺酰胺衍生物
CN1639159A (zh)	2005-07-13	N－氨基乙酰基－吡咯烷－2－腈和它们作为ddp－iv抑制剂的用途
CN1753668A (zh)	2006-03-29	1,5－二芳基吡咯－3－羧酰胺衍生物及其作为大麻素受体调节剂的应用
CN1665502A (zh)	2005-09-07	Mchir拮抗剂
CN1922162A (zh)	2007-02-28	烷基哌嗪－和烷基高哌嗪－羧酸酯衍生物、其制备方法及其作为faah酶抑制剂的用途
CN1845921A (zh)	2006-10-11	金刚烷和氮杂双环－辛烷及壬烷衍生物、其制备方法及其作为dpp－iv抑制剂的用途
CN1032438A (zh)	1989-04-19	新的取代的n-(1-烷基-3-羟基-4-哌啶基)苯甲酰胺
CN1922138A (zh)	2007-02-28	芳氧基烷基氨基甲酸酯类衍生物,它们的制备方法与治疗用途
CN1361775A (zh)	2002-07-31	新的二苯基哌啶衍生物
CN1642913A (zh)	2005-07-20	用作趋化因子受体活性(尤其是ccr5)调节剂的哌啶或8－氮杂－二环[3.2.1]辛－3－基衍生物
CN101058564A (zh)	2007-10-24	芳基烷基氨基甲酸酯衍生物的生产及其在治疗中的用途
CN1152879C (zh)	2004-06-09	萘啶衍生物
JP2007524706A (ja)	2007-08-30	ピペリジニルアルキルカーバメートの誘導体、これらの製造方法及びｆａａｈ酵素インヒビターとしての使用
CN101048393A (zh)	2007-10-03	作为γ－分泌酶抑制剂的取代的N－芳基磺酰基杂环胺